Skip Navigation



Hum. Reprod. Advance Access published online on May 19, 2005
Human Reproduction, doi:10.1093/humrep/dei107
This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/9/2623    most recent
dei107v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bellver, J.
Right arrow Articles by Serra, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bellver, J.
Right arrow Articles by Serra, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
Received March 22, 2005
Revised April 21, 2005
Accepted May 2, 2005

Article

First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction

José Bellver 1*, Coral Lara 2, Sergio R. Soares 3, Alberto Ramírez 3, Antonio Pellicer 3, José Remohí 3, and Vicente Serra 2

1 Unidad de Medicina Materno-Fetal, Instituto Universitario IVI, Universidad de Valencia, Valencia, Spain and Unidad de Reproducción, Instituto Universitario IVI, Universidad de Valencia, Valencia, Spain
2 Unidad de Medicina Materno-Fetal, Instituto Universitario IVI, Universidad de Valencia, Valencia, Spain
3 Unidad de Reproducción, Instituto Universitario IVI, Universidad de Valencia, Valencia, Spain

* To whom correspondence should be addressed.
José Bellver, E-mail: jbellver{at}ivi.es


  Abstract

BACKGROUND: Serum biochemical markers [free {beta}hCG (f{beta}hCG); pregnancy-associated plasma protein-A (PAPP-A)] used in first trimester Down's syndrome screening have not been fully investigated in pregnancies achieved by assisted reproduction techniques. We present data on pregnancies conceived by all types of assisted reproduction techniques, including pregnancies following ovum donation (OD) and a large sample by ICSI. METHODS: First trimester Down's syndrome screening was performed in 1054 normal singleton pregnancies: natural conception (n=498), ovulation induction (OS, n=97), IVF (n=47), ICSI (n=222) and OD (n=190). RESULTS: No differences in maternal levels of f{beta}hCG and PAPP-A, measured by the Kryptor system, appeared between naturally conceived pregnancies (n=498) and those obtained with assisted reproduction techniques (n=556). Several differences were apparent when comparing f{beta}hCG levels between different technologies but PAPP-A levels only differed between OS and IVF pregnancies (P<0.05). In a further small study, no differences were observed using frozen embryos (n=37), preimplantation genetic diagnosis (n=53) or sperm from testicular biopsy (n=21). CONCLUSIONS: Data accumulated so far suggest that first trimester biochemical markers either do not need any adjustments (e.g. in pregnancies obtained after OS and ICSI), or have very little impact (e.g. IVF pregnancies) or no impact (e.g. OD pregnancies) on the false positive rates.

Keywords: assisted reproduction; Down's syndrome screening; first trimester; free {beta}hCG; pregnancy-associated plasma protein-A.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
D.J. Amor, J.X. Xu, J.L. Halliday, I. Francis, D.L. Healy, S. Breheny, H.W.G. Baker, and A.M. Jaques
Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome
Hum. Reprod., June 1, 2009; 24(6): 1330 - 1338.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.